Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohort.
<h4>Objective</h4>To evaluate circulating visfatin and its relationship with disease activity and serum lipids in patients with early, treatment-naïve rheumatoid arthritis (RA).<h4>Methods</h4>Serum visfatin was measured in 40 patients with early RA before and after three mon...
Guardado en:
Autores principales: | Ondřej Sglunda, Heřman Mann, Hana Hulejová, Markéta Kuklová, Ondřej Pecha, Lenka Pleštilová, Mária Filková, Karel Pavelka, Jiří Vencovský, Ladislav Senolt |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0bd7bb5641ab4e61903bd3466fc3bf5c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis
por: Klára Prajzlerová, et al.
Publicado: (2021) -
Clusterin serum levels are elevated in patients with early rheumatoid arthritis and predict disease activity and treatment response
por: Tereza Kropáčková, et al.
Publicado: (2021) -
S100A11 (calgizzarin) is released via NETosis in rheumatoid arthritis (RA) and stimulates IL-6 and TNF secretion by neutrophils
por: Adéla Navrátilová, et al.
Publicado: (2021) -
Serum chemerin and visfatin levels and their ratio as possible diagnostic parameters of rheumatoid arthritis
por: Dunia Ali, et al.
Publicado: (2020) -
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
por: Hana Štorkánová, et al.
Publicado: (2021)